JP2021518392A5 - - Google Patents
Info
- Publication number
- JP2021518392A5 JP2021518392A5 JP2020550648A JP2020550648A JP2021518392A5 JP 2021518392 A5 JP2021518392 A5 JP 2021518392A5 JP 2020550648 A JP2020550648 A JP 2020550648A JP 2020550648 A JP2020550648 A JP 2020550648A JP 2021518392 A5 JP2021518392 A5 JP 2021518392A5
- Authority
- JP
- Japan
- Prior art keywords
- disease
- composition according
- auc last
- disorders
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862646845P | 2018-03-22 | 2018-03-22 | |
| US62/646,845 | 2018-03-22 | ||
| PCT/US2019/023338 WO2019183333A1 (en) | 2018-03-22 | 2019-03-21 | Bifunctional blood brain therapies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021518392A JP2021518392A (ja) | 2021-08-02 |
| JP2021518392A5 true JP2021518392A5 (enExample) | 2022-03-28 |
Family
ID=67986347
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020550648A Pending JP2021518392A (ja) | 2018-03-22 | 2019-03-21 | 二官能性血液脳治療 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20210046149A1 (enExample) |
| EP (1) | EP3818077A4 (enExample) |
| JP (1) | JP2021518392A (enExample) |
| KR (1) | KR20210004995A (enExample) |
| CN (1) | CN112292393A (enExample) |
| AU (1) | AU2019240218A1 (enExample) |
| CA (1) | CA3094179A1 (enExample) |
| IL (1) | IL277395A (enExample) |
| WO (1) | WO2019183333A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4004242A1 (de) | 2019-07-26 | 2022-06-01 | Duesenfeld GmbH | Verfahren zum verwerten von lithium-batterien |
| US20210355468A1 (en) * | 2020-05-18 | 2021-11-18 | Bioasis Technologies, Inc. | Compositions and methods for treating lewy body dementia |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103747807B (zh) * | 2011-07-05 | 2016-12-07 | 比奥阿赛斯技术有限公司 | P97‑抗体缀合物和使用方法 |
| AU2014243816B2 (en) * | 2013-03-13 | 2019-01-31 | Bioasis Technologies Inc. | Fragments of p97 and uses thereof |
-
2019
- 2019-03-21 JP JP2020550648A patent/JP2021518392A/ja active Pending
- 2019-03-21 CN CN201980034119.1A patent/CN112292393A/zh active Pending
- 2019-03-21 US US16/981,627 patent/US20210046149A1/en not_active Abandoned
- 2019-03-21 WO PCT/US2019/023338 patent/WO2019183333A1/en not_active Ceased
- 2019-03-21 KR KR1020207029940A patent/KR20210004995A/ko not_active Ceased
- 2019-03-21 AU AU2019240218A patent/AU2019240218A1/en not_active Abandoned
- 2019-03-21 CA CA3094179A patent/CA3094179A1/en active Pending
- 2019-03-21 EP EP19772184.8A patent/EP3818077A4/en not_active Withdrawn
-
2020
- 2020-09-16 IL IL277395A patent/IL277395A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6403062B2 (ja) | 組織修復活性組成物及びその利用 | |
| JP2013533858A5 (enExample) | ||
| JP2019519528A5 (enExample) | ||
| EP0585705A1 (en) | Use of anti-TNF to treat bacterial meningitis | |
| CA2730789A1 (en) | Treatment of inflammatory bowel diseases with mammal beta defensins | |
| JPWO2019156137A5 (enExample) | ||
| JP2021075550A (ja) | グルカゴン類似ペプチド−１受容体亢進剤を含む筋減少症治療用薬学組成物 | |
| JP2020517627A5 (enExample) | ||
| JP2025122021A5 (enExample) | ||
| JP2020535161A5 (enExample) | ||
| JP2021518392A5 (enExample) | ||
| JP2007500741A (ja) | 一時的処置のための短い半減期を有するｃ１インヒビター | |
| US8956605B2 (en) | Prevention and/or treatment of multiple organ dysfunction syndrome with interleukin-22 | |
| US7947283B2 (en) | Compositions and methods for treating psoriasis by Ganoderma lucidum (Reishi) polysaccharides | |
| JP2023545084A5 (enExample) | ||
| Lam et al. | Targeting mesenchymal stem cell therapy for severe pneumonia patients | |
| CN108939074A (zh) | 治疗再生障碍性贫血的方法和药物组合物 | |
| JP2015524431A5 (ja) | 視神経損傷、眼虚血または眼の再灌流傷害を治療または予防する医薬 | |
| KR20220024463A (ko) | 시뉴클레인병증에 대한 치료 | |
| CN115279344A (zh) | 盐酸米托蒽醌脂质体的用途 | |
| WO2025080877A3 (en) | Therapeutic peptides | |
| JP2020524132A5 (enExample) | ||
| JP2022543598A5 (enExample) | ||
| JP2021533113A5 (enExample) | ||
| JP2022521266A5 (enExample) |